US venture capital provider Battelle Ventures has spun out regenerative medicine start-up company NellOne Therapeutics from the
By Neil Eisberg | July 7, 2008
US venture capital provider Battelle Ventures has spun out regenerative medicine start-up company NellOne Therapeutics from the US Department of Energy's Oak Ridge National Laboratory. The new company will specialise in the development of protein therapeutics with the potential to restore tissue mass and function after a heart attack.
COPYRIGHT 2008 Society of Chemical
Industry Reproduced with permission of the copyright holder. Further reproduction or distribution is prohibited without permission.
Copyright 2008 Gale, Cengage Learning. All rights reserved. Gale Group is a Thomson Corporation Company.
NOTE: All illustrations and photos have been removed from this article.
Copyright 2008 Gale, Cengage Learning. All rights reserved. Gale Group is a Thomson Corporation Company.
NOTE: All illustrations and photos have been removed from this article.